Replies to post #244668 on Biotech Values

[DewDiligence]

CBIO reorganization is unduly complex, IMO:

https://www.globenewswire.com/news-release/2022/12/27/2579778/0/en/Catalyst-Biosciences-Completes-First-Steps-in-Reverse-Merger-Plan.html

If it takes multiple readings of the PR to (maybe) understand how the deal works, there’s a problem.